Cancer Commons News and Events

Image credit: Caroline Davis2010

Medical Director Kevin Knopf Discusses Cancer Commons in Xconomy Article

June 10, 2017

In a recent Xconomy article on cancer DNA testing, Cancer Commons medical director Kevin Knopf shares his perspective: “To help all patients we think an open-source database has the most utility,” says Knopf. Instead of current tests that list a patient’s mutations and potential drugs to use, a report should rank therapies the way online travel sites rank best options. Read the full article… Read more »

Marty Tenenbaum Presents a New Path to FDA Drug Approval at PMWC

June 6, 2017

Last week, Cancer Commons founder Marty Tenenbaum spoke at the Precision Medicine World Conference (PMWC) in Durham, NC. He presented a proposal to significantly accelerate patient access to promising investigational drugs, using a new pathway to approval by the U.S. Food and Drug Administration (FDA). The proposed Conditional Approval pathway aims to help cancer patients who may have exhausted existing options access new, promising treatments. “It’s… Read more »

Cancer Commons Community Member Spotlight: Sheri Sobrato Brisson

May 2, 2017

Since the beginning of high school, Cancer Commons supporter Sheri Sobrato Brisson has been working with families facing pediatric illness. “As soon as I was 16, I started volunteering in hospitals with kids with cancer, not knowing that I would grow up one day to be one of those patients myself,” she says. At the age of 24, Sheri faced her own diagnosis: a… Read more »

Marty Tenenbaum to Speak at Precision Medicine World Conference on May 24

April 25, 2017

Cancer Commons founder Marty Tenenbaum, Ph.D., will speak at the upcoming Precision Medicine World Conference (PMWC) in Durham, NC, which runs May 24–25. Marty, who founded Cancer Commons after his own battle with melanoma, will discuss the organization’s ongoing efforts to address challenges to knowledge-sharing in precision oncology. Read the synopsis of Marty’s presentation, entitled “Is An Additional Path to FDA Approval Possible?”: This talk will… Read more »

Cancer Commons Medical Director Kevin Knopf to Speak at TiEcon 2017

April 17, 2017

Oncologist and Cancer Commons Medical Director Kevin Knopf, MD, will speak next month at TiEcon 2017, a technology conference in Santa Clara, CA. He’ll join three other experts to discuss the future of personalized medicine. From the program: A new era of personalized medicine has made its way into the world of healthcare. We will discuss novel approaches for designing disease treatment and prevention that… Read more »

Cancer Commons Community Member Spotlight: Nancy Kanwisher

April 4, 2017

Ask MIT Neuroscientist Dr. Nancy Kanwisher what the most fascinating discovery about the human brain is in her eyes; she’ll tell you there’s a part of our brain that is selectively turned on only when we’re thinking about what other people are thinking about us. Though it was Dr. Kanwisher’s student and now colleague who made this discovery, she considers it the “coolest” of… Read more »

Connor (far left) with his family on a backpacking trip through the Lamar Valley in Yellowstone National Park

Volunteer Spotlight: Connor Sweetnam Captures Valuable Treatment Insights from ASK Cancer Commons

March 6, 2017

Volunteers are essential members of the Cancer Commons community. We are deeply grateful to those who have generously donated their time to helping us change the way the world treats cancer. This month, we celebrate the contributions of Cancer Commons volunteer Connor Sweetnam, who uses his engineering background to extract insights from our interactions with patients so they can be leveraged to help other… Read more »

Cancer Commons Participates in Lively Discussion of Precision Medicine at PMWC 2017

February 3, 2017

Update 3-1-17: A video of this event has now been released. Watch it below. This year’s Precision Medicine World Conference in Mountain View, California, was well-attended by many members of Cancer Commons, who shared in the scientific discoveries that will lead the way to more personalized, accurate, and effective cancer care. Precision medicine is a rapidly evolving field with many breakthroughs in science, technology,… Read more »

Cancer Commons Community Member Spotlight: Brit d’Arbeloff

February 2, 2017

One of Cancer Commons’ earliest and most generous supporters, Brit d’Arbeloff, is a woman of many talents who is dedicated to excellence in education. She is the first woman to earn an undergraduate mechanical engineering degree at Stanford University. In addition, she was the owner of a fashion boutique in Boston for over a decade. She also earned a graduate degree at MIT, where… Read more »

Thank You to Our 2016 Donors!

January 27, 2017

Everyone at Cancer Commons is very thankful for the outpouring of support that we received in 2016. As a nonprofit organization, we rely entirely on donations to provide cancer treatment decision support at no charge. These contributions have allowed Cancer Commons to respond to over 1,500 requests for help and will allow us to develop innovative technology to help many others in the months… Read more »